ZTS - Zoetis Inc.

NYSE - NYSE Delayed Price. Currency in USD
102.40
-0.49 (-0.48%)
At close: 4:04PM EDT
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close102.89
Open103.50
Bid101.98 x 800
Ask103.03 x 800
Day's Range102.32 - 104.41
52 Week Range78.90 - 104.41
Volume1,249,602
Avg. Volume1,989,159
Market Cap49.014B
Beta (3Y Monthly)0.64
PE Ratio (TTM)35.80
EPS (TTM)2.86
Earnings DateJul 31, 2019 - Aug 5, 2019
Forward Dividend & Yield0.66 (0.64%)
Ex-Dividend Date2019-07-18
1y Target Est109.27
  • Investors Who Bought Zoetis (NYSE:ZTS) Shares Five Years Ago Are Now Up 234%
    Simply Wall St.4 days ago

    Investors Who Bought Zoetis (NYSE:ZTS) Shares Five Years Ago Are Now Up 234%

    When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

  • 3 Stocks to Buy Ahead of the Next Market Crash
    Motley Fool5 days ago

    3 Stocks to Buy Ahead of the Next Market Crash

    Whether it's imminent or not, it's always a good idea to be prepared.

  • Business Wire5 days ago

    Zoetis to Participate in the Stifel 2019 Dental & Veterinary Conference

    Zoetis Inc. (ZTS) will participate in the Stifel 2019 Dental & Veterinary Conference on Wednesday, May 29, 2019, in New York, N.Y. Clint Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics will represent the company and respond to questions from analysts.

  • Business Wire10 days ago

    Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2019 Dividend

    Zoetis held its annual meeting today in Short Hills, N.J., with Chairman Michael B. McCallister presiding over the business portion of the meeting and shareholder voting. Chief Executive Officer Juan Ramón Alaix discussed the company’s strong performance in 2018 and its strategies for continued growth and market leadership in the global animal health industry. Juan Ramón Alaix, Paul M. Bisaro, Frank A. D’Amelio and Michael B. McCallister have been elected as directors for three-year terms.

  • GuruFocus.com11 days ago

    5 Companies Hit 52-Week Highs

    As of late, multiple companies have manged to achieve yearly highs

  • Thomson Reuters StreetEvents13 days ago

    Edited Transcript of ZTS earnings conference call or presentation 2-May-19 12:30pm GMT

    Q1 2019 Zoetis Inc Earnings Call

  • Markit18 days ago

    See what the IHS Markit Score report has to say about Zoetis Inc.

    Zoetis Inc NYSE:ZTSView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for ZTS with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZTS. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $1.18 billion over the last one-month into ETFs that hold ZTS are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Which Pharmaceutical Stocks Are Outperforming All Other Stocks?
    Investor's Business Daily19 days ago

    Which Pharmaceutical Stocks Are Outperforming All Other Stocks?

    The best pharmaceutical stocks to buy have commonalities: Strong Composite Ratings and Relative Strength Ratings.

  • These 2 Drug Giants Beat Earnings Views; But Only One Entered Buy Range
    Investor's Business Daily23 days ago

    These 2 Drug Giants Beat Earnings Views; But Only One Entered Buy Range

    Teva stock toppled Thursday after the generic drug behemoth's first-quarter report "gave no reason for confidence," according to one analyst. Meanwhile, Zoetis stock moved into buy range.

  • Zoetis (ZTS) Earnings Beat Estimates in Q1, Revenues Miss
    Zacks23 days ago

    Zoetis (ZTS) Earnings Beat Estimates in Q1, Revenues Miss

    Zoetis???s (ZTS) earnings beat estimates but sales miss the same in the first quarter of 2019.

  • Zoetis Inc (ZTS) Q1 2019 Earnings Call Transcript
    Motley Fool23 days ago

    Zoetis Inc (ZTS) Q1 2019 Earnings Call Transcript

    ZTS earnings call for the period ending March 31, 2019.

  • JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now?
    Zacks23 days ago

    JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now?

    JAZZ vs. ZTS: Which Stock Is the Better Value Option?

  • Zoetis (ZTS) Tops Q1 Earnings Estimates
    Zacks23 days ago

    Zoetis (ZTS) Tops Q1 Earnings Estimates

    Zoetis (ZTS) delivered earnings and revenue surprises of 11.39% and -0.73%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press23 days ago

    Zoetis: 1Q Earnings Snapshot

    On a per-share basis, the Parsippany, New Jersey-based company said it had net income of 65 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 88 cents ...

  • Business Wire23 days ago

    Zoetis Announces First Quarter 2019 Results

    Zoetis $ZTS reports first quarter 2019 financial results.

  • The Top Pharma Stocks for 2019
    Investopedia24 days ago

    The Top Pharma Stocks for 2019

    Find out how the pharmaceutical industry is thriving, the new drugs that are coming to market, and the top pharmaceutical stocks for 2019.

  • 3 Things You Might Not Know About Zoetis
    Motley Fool24 days ago

    3 Things You Might Not Know About Zoetis

    The animal health leader is quietly running laps around the S&P 500.

  • Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?
    Zacks26 days ago

    Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

    Zoetis (ZTS) is expected to provide updates on the pipeline, when it reports first-quarter 2019 results on May 2.

  • Zoetis (ZTS) Hits Fresh High: Is There Still Room to Run?
    Zacks26 days ago

    Zoetis (ZTS) Hits Fresh High: Is There Still Room to Run?

    Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zackslast month

    Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Is Zoetis Inc.'s (NYSE:ZTS) CEO Pay Fair?
    Simply Wall St.last month

    Is Zoetis Inc.'s (NYSE:ZTS) CEO Pay Fair?

    Juan Alaix has been the CEO of Zoetis Inc. (NYSE:ZTS) since 2012. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at other big companies. Next, we'll consider growth that t...

  • Zacks.com featured expert Kevin Matras highlights: Cadence Design System, CSX, Celanese and Zoetis
    Zackslast month

    Zacks.com featured expert Kevin Matras highlights: Cadence Design System, CSX, Celanese and Zoetis

    Zacks.com featured expert Kevin Matras highlights: Cadence Design System, CSX, Celanese and Zoetis

  • 4 GARP Stocks to Scoop Up for Maximum Returns
    Zackslast month

    4 GARP Stocks to Scoop Up for Maximum Returns

    If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

  • Business Wirelast month

    Forbes Names Zoetis One of America’s Best Employers for Fourth Year in a Row

    “At Zoetis, we know our people shape our reputation as a great place to work and drive our success,” said Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications. Forbes determined its America’s Best Employers list based on an independent survey among a sample of 50,000 American employees working for companies with at least 1,000 people in their U.S. operations.

  • JAZZ vs. ZTS: Which Stock Is the Better Value Option?
    Zackslast month

    JAZZ vs. ZTS: Which Stock Is the Better Value Option?

    JAZZ vs. ZTS: Which Stock Is the Better Value Option?